on 19 Jan 2024
Last Applicant/ Owned by
CH-6928 Manno
CH
Serial Number
79195512 filed on 26th Jul 2016
Registration Number
5234473 registered on 04th Jul 2017
Correspondent Address
Jeffrey B. Sladkus
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
Pharmaceutical preparations, both prescription and over-the-counter, namely, pharmaceutical preparations for peptic ulcer and gastrooesophageal reflux disease (GORD), propulsives, intestinal anti-infectives, intestinal anti-inflammatory agents, oral pharmaceutical preparations for lowering blood glucose, Vitamin A and D, mixed vitamin preparations consisting of vitamins A and D, vitamin and minera Read More
Pharmaceutical preparations, both prescription and over-the-counter, namely, pharmaceutical preparations for peptic ulcer and gastrooesophageal reflux disease (GORD), propulsives, intestinal anti-infectives, intestinal anti-inflammatory agents, oral pharmaceutical preparations for lowering blood glucose, Vitamin A and D, mixed vitamin preparations consisting of vitamins A and D, vitamin and mineral preparations for medical use, vitamin C in the nature of ascorbic acid mixed vitamin preparations consisting partially of Vitamin C, calcium supplements, mineral supplements, anti-thrombotic agents, intravenous solutions, cardiac glycosides, class I and class III anti-arrhythmics, pharmaceutical preparations for cardiac stimulation excluding cardiac glycosides, Vasodilators used in the treatment of cardiac diseases, anti-adrenergic agents, pharmaceutical preparations for acting on arteriolar smooth muscle, Beta blocking agents, Selective calcium channel blockers, pharmaceutical preparations in the nature of Angiotensin Converting Enzyme inhibitors, pharmaceutical preparations in the nature of Angiotensin Converting Enzyme inhibitors combined with other pharmaceutical preparations, anti-fungals for systemic use, anti-infectives and antiseptics, excluding those combined with corticosteroids, oxytocics, plain corticosteroids for systemic use, thyroid preparations, anti-thyroid preparations, tetracyclines preparations, macrolides, lincosamides and streptogramins, aminoglycoside antibacterials, quinolone antibacterials, antimycotics for systemic use, direct acting antivirals, immune sera, bacterial vaccines, alkylating agents, anti-metabolites, plant alkaloids, cytotoxic antibiotics, hormone antagonists and related agents, namely, anti-estrogens, anti-androgens and enzyme inhibitors, immunosuppressive agents, antiinflammatory and antirheumatic preparations, non-steroids in the nature of butylpyrazolidines, acetic acid derivatives, oxicams, propionic acid derivatives, fenamates, Coxibs, muscle relaxants, peripherally acting agents in the nature of curare alkaloids and choline derivatives, antigout preparations, analgesics and antipyretics preparations, anti-migraine preparations, anti-epileptic preparations, anti-cholinergic agents, dopaminergic agents, anti-psychotics, anxiolytics, hypnotics and sedatives, antidepressants, parasympathomimetics, agents for use against amoebiasis and other protozoal diseases, anti-malarial preparation, adrenergics, inhalant anesthetics, adrenergics for systemic use, antihistamines for systemic use, diuretic agents
N/A
N/A
No 79195512
No Service/Collective Mark
No
No
No
No
No
Yes
Yes
No
No
Status Date | Action Taken |
---|---|
17th Nov 2024 | TOTAL INVALIDATION PROCESSED BY THE IB |
24th Sep 2024 | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB |
24th Sep 2024 | INVALIDATION PROCESSED |
20th Sep 2024 | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED |
19th Jan 2024 | CANCELLED SECTION 71 |
04th Jul 2022 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
03rd Nov 2017 | FINAL DECISION TRANSACTION PROCESSED BY IB |
13th Oct 2017 | NOTIFICATION PROCESSED BY IB |
10th Oct 2017 | FINAL DISPOSITION NOTICE SENT TO IB |
10th Oct 2017 | FINAL DISPOSITION PROCESSED |